Regencell Bioscience Holdings RGC
NASDAQ RGC
$6.19 -0.03 (-0.54%)
As of: Oct 1, 2026 · 11:41 AM EDT

Regencell Bioscience Holdings (RGC) Market Capitalization (2022 - 2025)

Updated

Regencell Bioscience Holdings' Market Capitalization came in at $273.27 million for the quarter ended Dec 31, 2025.

Analysis

Regencell Bioscience Holdings (RGC) Market Capitalization (2022 - 2025) Analysis & Trends

For the year ended Jun 30, 2025, Regencell Bioscience Holdings' Market Capitalization was $221.74 million.

  • Market Capitalization carries a three-year compound annual growth rate of 165.5% (years ended Jun 2022 to Jun 2025).
  • Going back by year, Market Capitalization was $1.17 million in the year ended Jun 30, 2024 (-85.2%), $7.94 million in the year ended Jun 30, 2023 (-33.0%) and $11.84 million in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Regencell Bioscience Holdings 80.94 Mn 74.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 273.27 Mn
Jun 30, 2025 221.74 Mn
Jun 30, 2024 1.17 Mn
Jun 30, 2023 7.94 Mn
Jun 30, 2022 11.84 Mn
API Access

Regencell Bioscience Holdings Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=RGC&period=max&api_key=YOUR_API_KEY